The Efficacy of Recombinant Activated Factor VII in Severe Trauma

Annals of Emergency Medicine

Volumn 54, Issue 5, 2009, Pages

  Nishijima, Daniel K ^a   Zehtabchi, Shahriar ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 7; PLACEBO; BLOOD CLOTTING FACTOR 7A; COAGULATING AGENT; RECOMBINANT FVIIA; RECOMBINANT PROTEIN;

ARTICLE; BLOOD TRANSFUSION; BLUNT TRAUMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG COST; DRUG EFFICACY; DRUG SAFETY; EMERGENCY WARD; EVIDENCE BASED MEDICINE; HEMOSTASIS; HUMAN; INJURY; INJURY SCALE; MORTALITY; OUTCOME ASSESSMENT; PENETRATING TRAUMA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECOMMENDED DRUG DOSE; THROMBOEMBOLISM; BLEEDING; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG ADMINISTRATION; EMERGENCY HEALTH SERVICE; EVIDENCE BASED EMERGENCY MEDICINE; FEMALE; MALE; MULTIPLE TRAUMA; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK ASSESSMENT; SURVIVAL; TREATMENT OUTCOME;

BLOOD LOSS, SURGICAL; COAGULANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; EMERGENCY SERVICE, HOSPITAL; EVIDENCE-BASED EMERGENCY MEDICINE; FACTOR VIIA; FEMALE; HEMORRHAGE; HUMANS; INJURY SEVERITY SCORE; MALE; MULTIPLE TRAUMA; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECOMBINANT PROTEINS; RISK ASSESSMENT; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 70350045283     PISSN: 01960644     EISSN: 10976760     Source Type: Journal    
DOI: 10.1016/j.annemergmed.2009.01.027     Document Type: Article

References (54)

1. Lusher J.M., Roberts H.R., Davignon G., et al. A randomized, double-blind comparison of two dosage levels of recombinant factor VIIa in the treatment of joint, muscle and mucocutaneous haemorrhages in persons with haemophilia A and B, with and without inhibitors. rFVIIa Study Group. Haemophilia 4 (1998) 790-798
2. Bosch J., Thabut D., Bendtsen F., et al. Recombinant factor VIIa for upper gastrointestinal bleeding in patients with cirrhosis: a randomized, double-blind trial. Gastroenterology 127 (2004) 1123-1130
3. Diprose P., Herbertson M.J., O'Shaughnessy D., et al. Activated recombinant factor VII after cardiopulmonary bypass reduces allogeneic transfusion in complex non-coronary cardiac surgery: randomized double-blind placebo-controlled pilot study. Br J Anaesth 95 (2005) 596-602
4. Friederich P.W., Henny C.P., Messelink E.J., et al. Effect of recombinant activated factor VII on perioperative blood loss in patients undergoing retropubic prostatectomy: a double-blind placebo-controlled randomised trial. Lancet 361 (2003) 201-205
5. Lodge J.P., Jonas S., Oussoultzoglou E., et al. Recombinant coagulation factor VIIa in major liver resection: a randomized, placebo-controlled, double-blind clinical trial. Anesthesiology 102 (2005) 269-275
6. Raobaikady R., Redman J., Ball J.A., et al. Use of activated recombinant coagulation factor VII in patients undergoing reconstruction surgery for traumatic fracture of pelvis or pelvis and acetabulum: a double-blind, randomized, placebo-controlled trial. Br J Anaesth 94 (2005) 586-591
7. Ferrera P.C., and Bartfield J.M. Outcomes of anticoagulated trauma patients. Am J Emerg Med 17 (1999) 154-156
8. Karni A., Holtzman R., Bass T., et al. Traumatic head injury in the anticoagulated elderly patient: a lethal combination. Am Surg 67 (2001) 1098-1100
9. Li J., Brown J., and Levine M. Mild head injury, anticoagulants, and risk of intracranial injury. Lancet 357 (2001) 771-772
10. Mina A.A., Knipfer J.F., Park D.Y., et al. Intracranial complications of preinjury anticoagulation in trauma patients with head injury. J Trauma 53 (2002) 668-672
11. Hind D., Lloyd-Jones M., Makris M., et al. Recombinant factor VIIa concentrate versus plasma derived concentrates for the treatment of acute bleeding episodes in people with haemophilia A and inhibitors. Cochrane Database Syst Rev 2 (2004) CD004449
12. Stanworth S.J., Birchall J., Doree C.J., et al. Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia. Cochrane Database Syst Rev 2 (2007) CD005011
13. Hess J.R., and Lawson J.H. The coagulopathy of trauma versus disseminated intravascular coagulation. J Trauma 60 (2006) S12-S19
14. Brohi K., Singh J., Heron M., et al. Acute traumatic coagulopathy. J Trauma 54 6 (2003) 1127-1130
15. Barret J.P., and Gomez P.A. Disseminated intravascular coagulation: a rare entity in burn injury. Burns 31 (2005) 354-357
16. Hofmann S., Huemer G., Kratochwill C., et al. [Pathophysiology of fat embolisms in orthopedics and traumatology]. Orthopade 24 (1995) 84-93
17. Demetriades D., Martin M., Salim A., et al. Relationship between American College of Surgeons trauma center designation and mortality in patients with severe trauma (Injury Severity Score > 15). J Am Coll Surg 202 (2006) 212-215
18. Champion H.R., Sacco W.J., Copes W.S., et al. A revision of the Trauma Score. J Trauma 29 (1989) 623-629
19. Zehtabchi S., Baron B.J., Sinert R., et al. Ethanol and illicit drugs do not affect the diagnostic utility of base deficit and lactate in differentiating minor from major injury in trauma patients. Acad Emerg Med 11 (2004) 1014-1020
20. Malone D.L., Hess J.R., and Fingerhut A. Massive transfusion practices around the globe and a suggestion for a common massive transfusion protocol. J Trauma 60 6 suppl (2006) S91-S96
21. Wilson R.F., Mammen E., and Walt A.J. Eight years of experience with massive blood transfusions. J Trauma 11 (1971) 275-285
22. Sperry J.L., Ochoa J.B., Gunn S.R., et al. An FFP:PRBC transfusion ratio >/=1:1.5 is associated with a lower risk of mortality after massive transfusion. J Trauma 65 (2008) 986-993
23. Kashuk J.L., Moore E.E., Johnson J.L., et al. Postinjury life threatening coagulopathy: is 1:1 fresh frozen plasma:packed red blood cells the answer?. J Trauma 65 (2008) 261-270
24. Duchesne J.C., Hunt J.P., Wahl G., et al. Review of current blood transfusions strategies in a mature level I trauma center: were we wrong for the last 60 years?. J Trauma 65 (2008) 272-276
25. Narayan R.K., Maas A.I., Marshall L.F., et al. Recombinant factor VIIA in traumatic intracerebral hemorrhage: results of a dose-escalation clinical trial. Neurosurgery 62 (2008) 776-786
26. Guyatt G.H., Thompson P.J., Berman L.B., et al. How should we measure function in patients with chronic heart and lung disease?. J Chronic Dis 38 (1985) 517-524
27. Wennberg J.E. Outcomes research, cost containment, and the fear of health care rationing. N Engl J Med 323 (1990) 1202-1204
28. Spertus J., Peterson E., Conard M.W., et al. Monitoring clinical changes in patients with heart failure: a comparison of methods. Am Heart J 150 (2005) 707-715
29. Vickrey B.G. Getting oriented to patient-oriented outcomes. Neurology 53 (1999) 662-663
30. Guyatt G.H., Feeny D.H., and Patrick D.L. Measuring health-related quality of life. Ann Intern Med 118 (1993) 622-629
31. Spertus J.A. Evolving applications for patient-centered health status measures. Circulation 118 (2008) 2103-2110
32. Cummins R.O., Chamberlain D.A., Abramson N.S., et al. Recommended guidelines for uniform reporting of data from out-of-hospital cardiac arrest: the Utstein Style. A statement for health professionals from a task force of the American Heart Association, the European Resuscitation Council, the Heart and Stroke Foundation of Canada, and the Australian Resuscitation Council. Circulation 84 (1991) 960-975
33. Bonita R., and Beaglehole R. Recovery of motor function after stroke. Stroke 19 (1988) 1497-1500
34. Ranucci M., Isgro G., Soro G., et al. Efficacy and safety of recombinant activated factor VII in major surgical procedures: systematic review and meta-analysis of randomized clinical trials. Arch Surg 143 (2008) 296-304
35. O'Connell K.A., Wood J.J., Wise R.P., et al. Thromboembolic adverse events after use of recombinant human coagulation factor VIIa. JAMA 295 (2006) 293-298
36. Wiley InterScience. The Cochrane library. http://www3.interscience.wiley.com/cgi-bin/mrwhome/106568753/HOME Accessed July 10, 2008
37. Center for Medical Education. Emergency medical abstracts. http://ccme.org Accessed July 10, 2008
38. BestBETS. Best evidence topics: BestBETS. http://bestbets.org Accessed July 10, 2008
39. Boffard K.D., Riou B., Warren B., et al. Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: two parallel randomized, placebo-controlled, double-blind clinical trials. J Trauma 59 (2005) 8-15
40. Argill J. Factor VIIa for intractable blood loss in trauma [BestBETS Web site]. http://www.bestbets.org/bet/bet.php?id=371 Accessed August 28, 2008
41. Hsia C.C., Chin-Yee I.H., and McAlister V.C. Use of recombinant activated factor VII in patients without hemophilia: a meta-analysis of randomized control trials. Ann Surg 248 (2008) 61-68
42. von Heymann C., Jonas S., Spies C., et al. Recombinant activated factor VIIa for the treatment of bleeding in major abdominal surgery including vascular and urological surgery: a review and meta-analysis of published data. Crit Care 12 (2008) R14
43. Evaluation of recombinant activated factor VII in severe bleeding (CONTROL) [ClinicalTrials.gov Web site]. http://www.clinicaltrials.gov/ct2/show/NCT00184548?term=factor+vii+and+trauma&rank=3 Accessed August 28, 2008
44. Guyatt G.H., Sackett D.L., Cook D.J., and Evidence-Based Medicine Working Group. Users' guides to the medical literature. II. How to use an article about therapy or prevention. A. Are the results of the study valid?. JAMA 270 (1993) 2598-2601
45. Guyatt G.H., Sackett D.L., Cook D.J., and Evidence-Based Medicine Working Group. Users' guides to the medical literature. II. How to use an article about therapy or prevention. B. What were the results and will they help me in caring for my patients?. JAMA 27 (1994) 59-63
46. Brohi K., Cohen M.J., Ganter M.T., et al. Acute traumatic coagulopathy: initiated by hypoperfusion: modulated through the protein C pathway?. Ann Surg 24 (2007) 812-818
47. Como J.J., Dutton R.P., Scalea T.M., et al. Blood transfusion rates in the care of acute trauma. Transfusion 44 (2004) 809-813
48. Gonzalez E.A., Moore F.A., Holcomb J.B., et al. Fresh frozen plasma should be given earlier to patients requiring massive transfusion. J Trauma 62 (2007) 112-119
49. MacLeod J.B., Lynn M., McKenney M.G., et al. Early coagulopathy predicts mortality in trauma. J Trauma 5 (2003) 39-44
50. Kenet G., Walden R., Eldad A., et al. Treatment of traumatic bleeding with recombinant factor VIIa. Lancet 354 (1999) 1879
51. ten Cate H., Bauer K.A., Levi M., et al. The activation of factor X and prothrombin by recombinant factor VIIa in vivo is mediated by tissue factor. J Clin Invest 92 (1993) 1207-1212
52. Ewald B. Post hoc choice of cut points introduced bias to diagnostic research. J Clin Epidemiol 59 (2006) 798-801
53. Sackett D.L., and Haynes R.B. The architecture of diagnostic research. BMJ 324 (2002) 539-541
54. Steele R.T.L. Principles of and Procedures of Statistics. 2nd ed. (1982), McGraw-Hill, London, England